STOCK TITAN

Vor Biopharma (VOR) SEC Filings, Jul 1-30, 2025

VOR NASDAQ

Vor Biopharma Inc. filings document a clinical-stage biotechnology issuer focused on telitacicept and autoimmune disease development. The record includes Form 8-K disclosures for operating and financial results, Regulation FD presentations, clinical and regulatory updates, material agreements, governance changes and capital-structure matters.

Proxy materials describe director elections, equity incentive plan matters, auditor ratification and annual-meeting voting procedures. Other filings address executive compensation arrangements, Nasdaq-listed common stock, a reverse stock split, equity plan share adjustments and security-holder rights tied to the company’s common stock and outstanding awards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.33%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.96%
Tags
proxy
-
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.57%
Tags
other
Form 4
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.23%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.23%
Tags
insider
-
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.23%
Tags
current report
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.23%
Tags
other
-
Schedule 13D/A
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.06%
Tags
other
-
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
31.72%
Tags
other
Form 144
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.40%
Tags
other

FAQ

How many Vor Biopharma (VOR) SEC filings are available on StockTitan?

StockTitan tracks 134 SEC filings for Vor Biopharma (VOR), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Vor Biopharma (VOR)?

The most recent SEC filing for Vor Biopharma (VOR) was filed on November 16, 2026.